The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to come in for tests to understand whether there’s a genetic risk for the condition.The country’s drug regulator, alongside Genomics England, is investigating whether a person’s genetics might make them more vulnerable to acute pancreatitis — a potential serious side effect…
Premium Content is available to subscribers only. Please login here to access content or go here to purchase a subscription.